title: Clinical inquiries. What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL?
abstract: No studies directly compare low-density lipoprotein (LDL) levels <70 mg/dL to levels of 71 to 100 mg/dL in very-high-risk patients. However, no evidence suggests a "floor" for LDL cholesterol levels beyond which further reductions of heart disease risk cannot be achieved. The target LDL cholesterol of <70 mg/dL is based on data extrapolated from RCTs. Comparing larger (80 mg) with smaller doses of atorvastatin shows that larger doses reduce LDL and major cardiac events more than smaller doses. No studies report patient-oriented outcomes of treatments for patients who fail to reach target LDL levels <100 mg/dL.
authors: Rush-Copley Family Medicine Residency Program, Rush Medical College, Aurora, IL USA.
authors: Carrie
authors: C
authors: Nelson
authors: Kristin
authors: K
authors: Hitchcock
authors: James A
authors: JA
authors: Bohlen
authors: Wail
authors: W
authors: Malaty
mesh_terms: D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D018570:Risk Assessment
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors